Partial compliance with antipsychotic medication is common in patients with schizophrenia

References

• Byrne MK, Deane FP, Lambert G, Coombs T. Enhancing medication adherence: clinician outcomes from the Medication Alliance training program. Aust N Z J Psychiatry 2004; 38: 246–253
   PubMed Web of Science ®Google Scholar
• Puschner B, Born A, Giessler A, Helm H, Becker T, Angermeyer MC. [Effects of interventions to improve compliance with antipsychotic medication in people suffering from schizophrenia: results of recent reviews]. Psychiatr Prax 2005; 32: 62–67
   PubMed Web of Science ®Google Scholar
• Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J Clin Psychiatry 2006; 67: 1114–1123
   PubMed Web of Science ®Google Scholar
• Kikkert MJ, Schene AH, Koeter MW, et al. Medication adherence in schizophrenia: exploring patients’, carers’ and professionals’ views. Schizophr Bull 2006; 32: 786–794
   PubMed Web of Science ®Google Scholar
• Perkins DO, Johnson JL, Hamer RM, et al. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res 2006; 83: 53–63
   PubMed Web of Science ®Google Scholar
• Tsang HW, Fung KM, Corrigan PW. Psychosocial treatment compliance scale for people with psychotic disorders. Aust N Z J Psychiatry 2006; 40: 561–569
   PubMed Web of Science ®Google Scholar
• Cooper D, Moisan J, Gregoire JP. Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia. J Clin Psychiatry 2007; 68: 818–825
   PubMed Web of Science ®Google Scholar
• van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 2007; 7: 55
   PubMed Web of Science ®Google Scholar
• Marcus SC, Olfson M. Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophr Bull 2008; 34: 173–180
   PubMed Web of Science ®Google Scholar
• Woltmann EM, Valenstein M, Welsh DE, et al. Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness. Psychiatr Serv 2007; 58: 864–867
   PubMed Web of Science ®Google Scholar
• Kissling W. Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatr Scand Suppl 1994; 382: 16–24
   PubMedGoogle Scholar
• Leucht S, Barnes TR, Kissling W, Engel RR, Correll C, Kane JM. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry 2003; 160: 1209–1222
   PubMed Web of Science ®Google Scholar
• Hogarty GE, Ulrich RF. Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients. Arch Gen Psychiatry 1977; 34: 297–301
   PubMed Web of Science ®Google Scholar
• Robinson DG, Woerner MG, Alvir JM, Bilder RM, Hinrichsen GA, Lieberman JA. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res 2002; 57: 209–219
   PubMed Web of Science ®Google Scholar
• Giner J, Canas F, Olivares JM, et al. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions]. Acta Esp Psiquiatr 2006; 34: 386–392
   PubMed Web of Science ®Google Scholar
• Velligan DI, Lam YW, Glahn DC, et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 2006; 32: 724–742
   PubMed Web of Science ®Google Scholar
• Seale C, Chaplin R, Lelliott P, Quirk A. Sharing decisions in consultations involving anti-psychotic medication: a qualitative study of psychiatrists’ experiences. Soc Sci Med 2006; 62: 2861–2873
   PubMed Web of Science ®Google Scholar
• Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 2004; 55: 886–891
   PubMed Web of Science ®Google Scholar
• Eaddy M, Grogg A, Locklear J. Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clin Ther 2005; 27: 263–272
   PubMed Web of Science ®Google Scholar
• Day JC, Bentall RP, Roberts C, et al. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 2005; 62: 717–724
   PubMed Web of Science ®Google Scholar
• Kim SW, Yoon JS, Choi SK. Survey of medication adherence in patients with schizophrenia: Korean ADHES data. Hum Psychopharmacol 2006; 21: 533–537
   PubMed Web of Science ®Google Scholar
• Byerly M, Fisher R, Whatley K, et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 2005; 133: 129–133
   PubMed Web of Science ®Google Scholar
• Schooler NR. Relapse and rehospitalization: comparing oral and depot antipsychotics. J Clin Psychiatry 2003; 64(Suppl 16)14–17
   PubMed Web of Science ®Google Scholar
• Ayuso-Gutierrez JL, del Rio Vega JM. Factors influencing relapse in the long-term course of schizophrenia. Schizophr Res 1997; 28: 199–206
   PubMed Web of Science ®Google Scholar
• Weiden P, Glazer W. Assessment and treatment selection for “revolving door” inpatients with schizophrenia. Psychiatr Q 1997; 68: 377–392
   PubMed Web of Science ®Google Scholar
• Jeffreys SE, Harvey CA, McNaught AS, Quayle AS, King MB, Bird AS. The Hampstead Schizophrenia Survey 1991. I: Prevalence and service use comparisons in an inner London health authority, 1986–1991. Br J Psychiatry 1997; 170: 301–306
   PubMed Web of Science ®Google Scholar
• Leach LS, Christensen H. A systematic review of telephone-based interventions for mental disorders. J Telemed Telecare 2006; 12: 122–129
   PubMed Web of Science ®Google Scholar
• Velligan DI, Diamond PM, Mintz J et al. The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull 2007 Oct 10 [Epub ahead of print]
   Web of Science ®Google Scholar
• Burton SC. Strategies for improving adherence to second-generation antipsychotics in patients with schizophrenia by increasing ease of use. J Psychiatr Pract 2005; 11: 369–378
   PubMedGoogle Scholar
• Kane JM. Review of treatments that can ameliorate nonadherence in patients with schizophrenia. J Clin Psychiatry 2006; 67(Suppl 5)9–14
   PubMed Web of Science ®Google Scholar
• Lasser RA, Bossie CA, Gharabawi GM, Turner M. Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone. Eur Psychiatry 2004; 19: 219–225
   PubMed Web of Science ®Google Scholar
• Hui CL, Chen EY, Kan CS, Yip KC, Law CW, Chiu CP. Detection of non-adherent behaviour in early psychosis. Aust N Z J Psychiatry 2006; 40: 446–451
   PubMed Web of Science ®Google Scholar
• Nasrallah HA. The case for long-acting antipsychotic agents in the post-CATIE era. Acta Psychiatr Scand 2007; 115: 260–267
   PubMed Web of Science ®Google Scholar
• Heres S, Hamann J, Kissling W, Leucht S. Attitudes of psychiatrists toward antipsychotic depot medication. J Clin Psychiatry 2006; 67: 1948–1953
   PubMed Web of Science ®Google Scholar
• Patel MX, Nikolaou V, David AS. Psychiatrists’ attitudes to maintenance medication for patients with schizophrenia. Psychol Med 2003; 33: 83–89
   PubMed Web of Science ®Google Scholar
• Pereira S, Pinto R. A survey of the attitudes of chronic psychiatric patients living in the community toward their medication. Acta Psychiatr Scand 1997; 95: 464–468
   PubMed Web of Science ®Google Scholar
• Lindenmayer JP, Jarboe K, Bossie CA, Zhu Y, Mehnert A, Lasser R. Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone. Int Clin Psychopharmacol 2005; 20: 213–221
   PubMed Web of Science ®Google Scholar
• Pekkala E , Merinder L . Psychoeducation for schizophrenia. Cochrane Database Syst Rev 2002; (2): CD002831.
   Google Scholar
• Pitschel-Walz G, Leucht S, Bäuml J, Kissling W, Engel RR. The effect of family interventions on relapse and rehospitalization in schizophrenia: a meta-analysis. Schizophr Bull 2001; 27: 73–92
   PubMed Web of Science ®Google Scholar
• Pitschel-Walz G, Bäuml J, Bender W, Engel RR, Wagner M, Kissling W. Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project Study. J Clin Psychiatry 2006; 67: 443–452
   PubMed Web of Science ®Google Scholar
• Olfson M, Marcus SC, Wilk J, West JC. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. Psychiatr Serv 2006; 57: 205–211
   PubMed Web of Science ®Google Scholar
• Rummel-Kluge C, Pitschel-Walz G, Kissling W. A fast, implementable psychoeducation program for schizophrenia. Psychiatr Serv 2007; 58: 1226
   PubMed Web of Science ®Google Scholar
• Bäuml J, Pitschel-Walz G, Volz A, Engel RR, Kessling W. Psychoeducation in schizophrenia: 7-year follow-up concerning rehospitalization and days in hospital in the Munich Psychosis Information Project Study. J Clin Psychiatry 2007; 68: 854–861
   PubMed Web of Science ®Google Scholar
• Rummel-Kluge C, Pitschel-Walz G, Bäuml J, Kissling W. Psychoeducation in schizophrenia: results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland. Schizophr Bull 2006; 32: 765–775
   PubMed Web of Science ®Google Scholar
• Dixon L, Stewart B, Burland J, Delahanty J, Lucksted A, Hoffman M. Pilot study of the effectiveness of the family-to-family education program. Psychiatr Serv 2001; 52: 965–967
   PubMed Web of Science ®Google Scholar
• Dixon L, Lucksted A, Stewart B, et al. Outcomes of the peer-taught 12-week family-to-family education program for severe mental illness. Acta Psychiatr Scand 2004; 109: 207–215
   PubMed Web of Science ®Google Scholar
• Rummel C, Pitschel-Walz G, Kissling W. [Family members inform family members”: family members as group moderators for psychoeducational groups in schizophrenia]. Psychiatr Prax 2005; 32: 87–92
   PubMed Web of Science ®Google Scholar
• Rummel CB, Hansen WP, Helbig A, Pitschel-Walz G, Kissling W. Peer-to-peer psychoeducation in schizophrenia: a new approach. J Clin Psychiatry 2005; 66: 1580–1585
   PubMed Web of Science ®Google Scholar
• Byerly MJ, Thompson A, Carmody T, et al. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv 2007; 58: 844–847
   PubMed Web of Science ®Google Scholar